Cargando…

Antifungal Efficacy of Amphotericin B in Candida Albicans Endocarditis Therapy: Systematic Review

INTRODUCTION: Although it is the most common agent among the fungal causes of endocarditis, Candida albicans endocarditis is rare. OBJECTIVE: To evaluate the efficacy of amphotericin B in the treatment of C. albicans endocarditis beyond a systematic review. DATA SEARCH: Articles in English, Spanish...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bezerra, Lucas Soares, da Silva, Janielli Assis, Santos-Veloso, Marcelo Antônio Oliveira, de Lima, Sandro Gonçalves, Chaves-Markman, Ândrea Virgínia, Jucá, Moacir Batista
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Cirurgia Cardiovascular 2020
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7598963/ https://www.ncbi.nlm.nih.gov/pubmed/33118745 http://dx.doi.org/10.21470/1678-9741-2019-0159

Ejemplares similares

Antifungal activity of caspofungin in experimental infective endocarditis caused by Candida albicans
por: Victorio, Gerardo Becerra, et al.
Publicado: (2017)

Post-antifungal effect of the combination of anidulafungin with amphotericin B and fluconazole against fluconazole-susceptible and -resistant Candida albicans
por: Vaseghi, Narges, et al.
Publicado: (2022)

Biofilm Formation and Susceptibility to Amphotericin B and Fluconazole in Candida albicans
por: Zarei Mahmoudabadi, Ali, et al.
Publicado: (2014)

Modes of the antibiotic activity of amphotericin B against Candida albicans
por: Grela, Ewa, et al.
Publicado: (2019)

Nicotinamide potentiates amphotericin B activity against Candida albicans
por: Yan, Yu, et al.
Publicado: (2022)

The influence of N and S poles of static magnetic field (SMF) on Candida albicans hyphal formation and antifungal activity of amphotericin B
por: Sztafrowski, Dariusz, et al.
Publicado: (2019)

Azole Antifungal Resistance in Candida albicans and Emerging Non-albicans Candida Species
por: Whaley, Sarah G., et al.
Publicado: (2017)

Efficacy of liposomal amphotericin B and anidulafungin using an antifungal lock technique (ALT) for catheter-related Candida albicans and Candida glabrata infections in an experimental model
por: Basas, Jana, et al.
Publicado: (2019)

Recurrent Candida albicans Ventriculitis Treated with Intraventricular Liposomal Amphotericin B
por: Toprak, Demet, et al.
Publicado: (2015)

Fungistatic Action of N-Acetylcysteine on Candida albicans Biofilms and Its Interaction with Antifungal Agents
por: Nunes, Thaís Soares Bezerra Santos, et al.
Publicado: (2020)

P031 Post-antifungal effect of the combination of a nidulafungin with amphotericin B and fluconazole against fluconazole-susceptible and resistant Candida albicans
por: Aslani, Narges
Publicado: (2022)

ICD indication in hypertrophic cardiomyopathy: which algorithm to use?
por: Santos-Veloso, Marcelo Antônio Oliveira, et al.
Publicado: (2022)

Evaluation of Antifungal Activity and Mechanism of Action of Citral against Candida albicans
por: Leite, Maria Clerya Alvino, et al.
Publicado: (2014)

Incidence and Antifungal Susceptibility of Candida Albicans Infections
por: UNGUREANU, A., et al.
Publicado: (2016)

Pseudomonas aeruginosa increases the susceptibility of Candida albicans to amphotericin B in dual-species biofilms
por: Alam, Farhana, et al.
Publicado: (2023)

Liquid and vapour-phase antifungal activities of essential oils against Candida albicans and non-albicans Candida
por: Mandras, Narcisa, et al.
Publicado: (2016)

Optimum Inhibition of Amphotericin-B-Resistant Candida albicans Strain in Single- and Mixed-Species Biofilms by Candida and Non-Candida Terpenoids
por: Touil, Hidaya F. Z., et al.
Publicado: (2020)

In Vitro Antifungal Activity of Equol against Candida albicans
por: Lee, Jeong Ah, et al.
Publicado: (2010)

Chloroquine sensitizes biofilms of Candida albicans to antifungal azoles
por: Shinde, Ravikumar Bapurao, et al.
Publicado: (2013)

Antifungal activity of amphotericin B and voriconazole against the biofilms and biofilm-dispersed cells of Candida albicans employing a newly developed in vitro pharmacokinetic model
por: El-Azizi, Mohamed, et al.
Publicado: (2015)

Synergistic Antifungal Activity of Synthetic Peptides and Antifungal Drugs against Candida albicans and C. parapsilosis Biofilms
por: Bezerra, Leandro P., et al.
Publicado: (2022)

Analysis of Biofilm-Related Genes and Antifungal Susceptibility Pattern of Vaginal Candida albicans and Non-Candida albicans Species
por: Mohammadi, Faezeh, et al.
Publicado: (2021)

The Bovhyaluronidase Azoximer (Longidaza(®)) Disrupts Candida albicans and Candida albicans-Bacterial Mixed Biofilms and Increases the Efficacy of Antifungals
por: Gatina, Alina, et al.
Publicado: (2022)

Huge Candida albicans normal native tricuspid valve endocarditis
por: Guerriero, Massimiliano, et al.
Publicado: (2018)

Capric acid secreted by Saccharomyces boulardii influences the susceptibility of Candida albicans to fluconazole and amphotericin B
por: Suchodolski, Jakub, et al.
Publicado: (2021)

High‐throughput assay for effect screening of amphotericin B and bioactive components on filamentous Candida albicans
por: Haslene‐Hox, Hanne, et al.
Publicado: (2022)

The synergistic effects of hydroxychavicol and amphotericin B towards yeast-hyphae transition and the germination of Candida albicans
por: Harun, Wan H.A.W., et al.
Publicado: (2023)

Hsp21 Potentiates Antifungal Drug Tolerance in Candida albicans
por: Mayer, François L., et al.
Publicado: (2013)

Effects of Chitosan on Candida albicans: Conditions for Its Antifungal Activity
por: Peña, Antonio, et al.
Publicado: (2013)

High Virulence and Antifungal Resistance in Clinical Strains of Candida albicans
por: Monroy-Pérez, Eric, et al.
Publicado: (2016)

Antifungal Activity of Oleuropein against Candida albicans—The In Vitro Study
por: Zorić, Nataša, et al.
Publicado: (2016)

Antifungal Activity of Coumarin Against Candida albicans Is Related to Apoptosis
por: Jia, Chang, et al.
Publicado: (2019)

Photodynamic Antifungal Activity of Hypocrellin A Against Candida albicans
por: Yang, Yijia, et al.
Publicado: (2019)

Systematic truncations of chromosome 4 and their responses to antifungals in Candida albicans
por: Uddin, Wasim, et al.
Publicado: (2021)

Antifungal Properties of Hydrazine-Based Compounds against Candida albicans
por: Camaioni, Louis, et al.
Publicado: (2023)

Autophagy Alters the Susceptibility of Candida albicans Biofilms to Antifungal Agents
por: Shen, Jiadi, et al.
Publicado: (2023)

Antifungal effects of eugenol on Candida albicans adherence to denture polymers
por: Zanul Abidin, Zubaidah, et al.
Publicado: (2023)

Candida albicans Antifungal Resistance and Tolerance in Bloodstream Infections: The Triad Yeast-Host-Antifungal
por: Costa-de-Oliveira, Sofia, et al.
Publicado: (2020)

Pharmacoeconomic analysis of antifungal therapy for primary treatment of invasive candidiasis caused by Candida albicans and non-albicans Candida species
por: Ou, Huang-Tz, et al.
Publicado: (2017)

Virulence and in vitro antifungal susceptibility of Candida albicans and Candida catenulata from laying hens
por: Rhimi, Wafa, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_cgrlrvr94u0ilj1fnvr8jt9i70